Winton Group LTD Denali Therapeutics Inc. Transaction History

Winton Group LTD

  • $1.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$29.0 - $47.27 $181,888 - $296,477
-6,272 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$42.59 - $55.02 $267,124 - $345,085
6,272 New
6,272 $280,000
Q1 2020

May 11, 2020
SELL
$14.2 - $27.98 $645,418 - $1.27 Million
-45,452 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$14.4 - $19.99 $654,508 - $908,585
45,452 New
45,452 $792,000

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.36B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email